Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jon Senkowsky

Vascular Surgery Arlington, TX Medical Doctor

NPI 1619976628 CMS profile 254753

4201 Interway Pl, Arlington, TX 76018

Open in the dashboard

General payments

$2,386

99 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jon Senkowsky of Arlington, TX is reported in the CMS Open Payments database as having received $2,386 across 99 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 33rd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $38 2
2024 General $51 2
2023 General $598 24
2022 General $699 27
2021 General $142 8
2020 General $518 16
2019 General $340 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jon Senkowsky
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jon Senkowsky were reported at $38. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jon Senkowsky Vascular Surgery median Middle half National median
2019 $340 $796 $226–$2,363 $163
2020 $518 $348 $118–$1,110 $114
2021 $142 $471 $158–$1,421 $132
2022 $699 $725 $222–$2,183 $149
2023 $598 $836 $257–$2,440 $160
2024 $51 $909 $252–$2,619 $164
2025 $38 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tactile Systems Technology Inc $281 17 payments
  2. Smith+Nephew, Inc. $276 14 payments
  3. Musculoskeletal Transplant Foundation Inc. $232 3 payments
  4. AbbVie, Inc. $194 10 payments
  5. Bard Peripheral Vascular, Inc. $142 1 payment
  6. Kerecis Limited $120 2 payments
  7. Shockwave Medical, Inc $104 2 payments
  8. Organogenesis Inc. $101 5 payments
  9. Integra LifeSciences Corporation $99 4 payments
  10. CVRx, Inc. $76 1 payment
  11. Other $761 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,376 98 payments
  2. Travel and Lodging $10 1 payment
Products named General payments · program years 2019–2025
  1. DALVANCE $245 13 payments
  2. Flexitouch Plus $177 10 payments
  3. TEFLARO $127 7 payments
  4. Vascular Lithotripsy $104 2 payments
  5. FLEXITOUCH $104 7 payments
  6. ACTITOUCH $104 7 payments
  7. ENTRE $104 7 payments
  8. AMNIOEXCEL $99 4 payments
  9. PRIMATRIX $99 4 payments
  10. TCC-EZ $99 4 payments
  11. Other $2,187 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

99 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record